Insulet Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (36)

Latest Posts

About This Stock More About This Stock
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
Article By: Tobias Carlisle
Sunday, March 31, 2024 7:10 PM EDT
Over the past 12 months, 10 Large-Cap stocks have underperformed all others.
In this article: ALB, EL, HUM, NEM, PFE, ILMN, PODD, WBA, ENPH, WBD
5 Stocks To Buy On The Dip To Gain From The Wall Street Rally
Article By: Zacks Investment Research
Saturday, March 23, 2024 1:20 PM EDT
Wall Street had a dream run in 2023, reversing the nightmare of 2022. The impressive bull run appears set to continue in 2024. Thus, here is a look at some stocks that may be worth buying on the dip during such an impressive rally.
In this article: AWK, NEE, PODD, TWLO, ZS
Top Stock Picks For Week Of December 25, 2023
Article By: Zacks Investment Research
Wednesday, December 27, 2023 8:15 PM EDT
MoneyLion Inc. is a data-driven, digital financial platform. Insulet Corporation is a leading developer, manufacturer, and marketer of the Omnipod Insulin Management System. 
In this article: PODD, ML
Insulet Corp (PODD) Under Pressure, Here’s The Next Major Support Level
Article By: Nick Santiago
Wednesday, July 14, 2021 11:53 AM EDT
Insulet Corp (PODD​​​​​​​) is a leading medical device developer and manufacturer of an insulin delivery system. The stock recently made a high on July 7th, 2021 at $290.00 a share.
In this article: PODD
Canaccord Upgrades Insulet To Buy Ahead Of Omnipod5 Launch
Article By: The Fly
Friday, March 19, 2021 10:55 AM EDT
Canaccord Genuity analyst Kyle Rose upgraded Insulet to Buy from Hold with an unchanged price target of $280.
In this article: PODD

Latest Tweets for $PODD

No tweets yet!